Welcome to our dedicated page for Patterson Cos news (Ticker: PDCO), a resource for investors and traders seeking the latest updates and insights on Patterson Cos stock.
Patterson Companies Inc (PDCO) delivers essential dental and veterinary supplies, equipment, and practice management solutions across North America and the UK. This news hub provides investors and healthcare professionals with timely updates on corporate developments, financial performance, and industry leadership.
Access consolidated coverage of PDCO's earnings announcements, product innovations, and strategic partnerships. Our repository includes press releases on dental technology integrations, veterinary supply chain expansions, and operational milestones impacting healthcare providers.
Key updates feature Patterson Dental's software advancements and Patterson Animal Health's diagnostic equipment launches. Track regulatory filings, leadership changes, and market positioning updates critical for informed analysis.
Bookmark this page for streamlined monitoring of PDCO's evolving role in healthcare distribution. Verify time-sensitive filings through official SEC sources while leveraging our aggregation for comprehensive market awareness.
Patterson Companies (PDCO) is set to be removed from the S&P SmallCap 600 index as Patient Square Capital is finalizing its acquisition of the company. The change will take effect prior to market opening on April 17, 2025.
Sterling Infrastructure (STRL) will replace Patterson Companies in the index. The modification reflects the pending completion of Patterson Companies' acquisition, subject to final closing conditions.
Patterson Companies (NASDAQ: PDCO), a specialty distributor in dental and animal health supply markets across the U.S., Canada, and U.K., has received shareholder approval for its acquisition by Patient Square Capital, a healthcare investment firm. Under the merger agreement dated December 10, 2024, shareholders will receive $31.35 in cash per share.
The transaction, expected to close later this month subject to customary conditions, will transform Patterson into a private company, delisting from NASDAQ. CEO Don Zurbay expressed gratitude to shareholders and enthusiasm for the partnership, stating it will enable continued investment in customer service, business growth, and strategic priorities.
Patterson Companies (PDCO) reported fiscal 2025 third quarter results with net sales declining 2.7% to $1.57 billion. The company posted GAAP earnings of $0.35 per diluted share and adjusted earnings of $0.43 per diluted share, both impacted by a cybersecurity attack on Change Healthcare.
Key financial highlights include:
- Net income decreased to $31.3 million from $47.7 million year-over-year
- Dental segment sales reached $596.3 million with internal sales declining 6.0%
- Animal Health segment reported sales of $972.4 million with internal sales up 0.2%
The company is in the process of being acquired by Patient Square Capital for $31.35 per share in an all-cash transaction valued at approximately $4.1 billion. The deal is expected to close in April 2025, after which Patterson will become private. Through the first nine months of fiscal 2025, Patterson returned $119.2 million to shareholders through dividends and share repurchases.
Patterson Companies (PDCO) has announced the expiration of its 40-day 'go-shop' period following the previously announced merger agreement with Patient Square Capital. The agreement involves Patient Square acquiring Patterson for $31.35 per share in an all-cash transaction valued at approximately $4.1 billion, including the refinancing of Patterson's receivables facilities.
During the go-shop period, which ended at 11:59 p.m. (Central Time) on January 19, 2025, Patterson had the right to solicit and consider alternative acquisition proposals. However, no alternative proposals were received from any third parties. The transaction is expected to close in April 2025, subject to shareholder approval and U.S. antitrust clearance. Upon completion, Patterson will become private, and its stock will be delisted from NASDAQ.
Patterson Companies (PDCO) has announced a definitive agreement to be acquired by Patient Square Capital in a transaction valued at approximately $4.1 billion. Under the terms, shareholders will receive $31.35 in cash per share, representing a 49% premium to Patterson's 30-day volume-weighted average price ending December 4, 2024.
The transaction, unanimously approved by the Board of Directors (excluding CEO Don Zurbay), includes a 40-day 'go-shop' period allowing Patterson to solicit alternative acquisition proposals. The deal is expected to close in Q4 of Patterson's fiscal 2025, subject to shareholder and regulatory approvals. Upon completion, Patterson will become private and delist from NASDAQ while maintaining its St. Paul, Minnesota headquarters.
Rectangle Health announced integrations with Patterson Dental Supply, a subsidiary of Patterson Companies (Nasdaq: PDCO). The integration connects Rectangle Health's Practice Management Bridge® platform with Patterson's dental practice management software solutions - Dolphin Management, Fuse, and Eaglesoft.
The collaboration aims to enhance payment processing capabilities for dental practices through features including:
- Streamlined payment processing workflows
- Multiple payment options including mobile, online, and contactless
- Automated payment reminders and Text to Pay functionality
- Improved cash flow and Accounts Receivable collection rates
Patterson Companies (NASDAQ: PDCO) reported Q2 fiscal 2025 results with net sales increasing 1.3% to $1.67 billion. The company posted GAAP earnings of $0.30 per diluted share and adjusted earnings of $0.47 per diluted share, both impacted by the cybersecurity attack on Change Healthcare.
The Dental segment saw internal sales decrease 2.3%, while Animal Health segment internal sales grew 1.9%. The company revised its fiscal 2025 guidance, with GAAP earnings expected between $1.83-$1.93 per share and adjusted earnings between $2.25-$2.35 per share.
Patterson returned $96.2 million to shareholders through dividends and share repurchases in the first six months of fiscal 2025. The company also announced it is evaluating strategic alternatives, including potential sale or merger options.
Patterson Companies (PDCO) has scheduled its fiscal 2025 second-quarter conference call for Thursday, December 5, 2024, at 7:30 a.m. CT (8:30 a.m. ET). The company will release its earnings report before market opening on the same day. Investors can access the live webcast through the investor relations section of Patterson's website. An audio replay will be available for one week following the call, accessible through pre-registration with a unique access code.
Patterson Dental Supply has extended its strategic partnership with PDS Health through 2027, maintaining its position as the premier distributor for PDS Health's network of over 1,000 supported practices across the United States. The agreement covers merchandise, services, technology, and core equipment distribution. The relationship, spanning more than 25 years, began with Patterson as PDS Health's core technology provider and expanded in 2020 to include comprehensive distribution services. This extension reinforces their shared commitment to advancing patient-centered care and healthcare delivery innovation.
Patterson Companies has appointed Kristin Dietzler as Patterson Dental's North American president. Dietzler, who brings nearly 30 years of healthcare services experience, will report to Chief Operating Officer Kevin Pohlman and join the executive leadership team. She previously served as president of Carestream Health's Americas Region, where she achieved significant growth in sales and new products. Prior roles include positions at Medtronic and Covidien, where she managed large sales organizations and indirect channels.
